SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-23-296811
Filing Date
2023-12-15
Accepted
2023-12-15 17:26:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-3 d866423df3.htm F-3 323553
2 EX-4.3 d866423dex43.htm EX-4.3 67507
3 EX-5.1 d866423dex51.htm EX-5.1 47831
4 EX-23.2 d866423dex232.htm EX-23.2 1714
5 EX-23.3 d866423dex233.htm EX-23.3 1955
6 EX-FILING FEES d866423dexfilingfees.htm EX-FILING FEES 36106
7 GRAPHIC g866423g1215181326049.jpg GRAPHIC 3107
8 GRAPHIC g866423g1215181326379.jpg GRAPHIC 7125
9 GRAPHIC g866423g79x61.jpg GRAPHIC 68195
10 GRAPHIC g866423g98g62.jpg GRAPHIC 69762
  Complete submission text file 0001193125-23-296811.txt   684564
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-3 | Act: 33 | File No.: 333-276091 | Film No.: 231491465
SIC: 2834 Pharmaceutical Preparations